Trex Company Q2 sales beat estimates, driven by volume growth
Trex Company Q2 sales beat estimates, driven by volume growth
Overview
U.S. decking maker's Q2 sales rose 8%, beating analyst expectations
Adjusted EPS for Q2 missed analyst expectations
Company approved additional $150 mln share buyback and reaffirmed full-year guidance
Outlook
Trex reaffirms full-year 2026 net sales guidance of $1.215 bln to $1.25 bln
Company expects Q3 2026 net sales between $305 mln and $320 mln
Trex targets $2 bln in annual revenue by 2030
Result Drivers
VOLUME GROWTH - Co said Q2 sales increase was driven mainly by broad-based volume growth across product lines, price points, and channels
CONSUMER DEMAND - Co cited improved consumer demand, especially for entry-level Trex Enhance decking, aided by marketing efforts to drive conversion from wood to composite
PRODUCTION INEFFICIENCIES - Co said gross margin was impacted by higher mix of railing sales, increased depreciation from Arkansas facility, and temporary production inefficiencies caused by uneven demand patterns
Company press release: ID:nBw2fcsXha
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Sales | Beat | $418.02 mln | $413.57 mln (19 Analysts) |
Q2 Adjusted EPS | Miss | $0.62 | $0.63 (20 Analysts) |
Q2 Adjusted Net Income | Miss | $63.20 mln | $65.46 mln (16 Analysts) |
Q2 Net Income |
| $61.88 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", 9 "hold" and 2 "sell" or "strong sell"
The average consensus recommendation for the construction supplies & fixtures peer group is "buy"
Wall Street's median 12-month price target for Trex Company Inc is $52.00, about 16% above its August 3 closing price of $44.83
The stock recently traded at 24 times the next 12-month earnings vs. a P/E of 23 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Trex
See all newsRetension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continues (updated)
Retension Pharmaceuticals, TRex Bio file for US IPO as biotech momentum continues
Brief: Trex Company Announces September 2026 Investor Conference Schedule
Trex Company Inc reports results for the quarter ended June 30 - Earnings Summary
Trex Company Q2 sales beat estimates, driven by volume growth